[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MD1780G2 - Metodă de tratament al pacienţilor cu ciroze hepatice - Google Patents

Metodă de tratament al pacienţilor cu ciroze hepatice

Info

Publication number
MD1780G2
MD1780G2 MDA20010032A MD20010032A MD1780G2 MD 1780 G2 MD1780 G2 MD 1780G2 MD A20010032 A MDA20010032 A MD A20010032A MD 20010032 A MD20010032 A MD 20010032A MD 1780 G2 MD1780 G2 MD 1780G2
Authority
MD
Moldova
Prior art keywords
patients
hepatic cirrhosis
treatment
hepatoprotectors
losartan
Prior art date
Application number
MDA20010032A
Other languages
English (en)
Russian (ru)
Other versions
MD1780F1 (ro
Inventor
Влада-Татьяна ДУМБРАВА
Eugen Tcaciuc
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MDA20010032A priority Critical patent/MD1780G2/ro
Publication of MD1780F1 publication Critical patent/MD1780F1/ro
Publication of MD1780G2 publication Critical patent/MD1780G2/ro

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Invenţia se referă la medicină, şi anume la hepatologie.Esenţa invenţiei constă în aceea că pacienţilor cu ciroze hepatice concomitent cu administrarea hepatoprotectoarelor şi vitaminelor suplimentar timp de 27…35 zile se administrează losartan câte 0,0125…0,025 g o dată pe zi per os.
MDA20010032A 2001-02-02 2001-02-02 Metodă de tratament al pacienţilor cu ciroze hepatice MD1780G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20010032A MD1780G2 (ro) 2001-02-02 2001-02-02 Metodă de tratament al pacienţilor cu ciroze hepatice

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20010032A MD1780G2 (ro) 2001-02-02 2001-02-02 Metodă de tratament al pacienţilor cu ciroze hepatice

Publications (2)

Publication Number Publication Date
MD1780F1 MD1780F1 (ro) 2001-11-30
MD1780G2 true MD1780G2 (ro) 2002-05-31

Family

ID=19739746

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20010032A MD1780G2 (ro) 2001-02-02 2001-02-02 Metodă de tratament al pacienţilor cu ciroze hepatice

Country Status (1)

Country Link
MD (1) MD1780G2 (ro)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4458C1 (ro) * 2014-06-19 2017-08-31 Мария ДАНУ Utilizarea preparatului Polibiolină în tratamentul bolnavilor cu ciroză hepatică

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Lebrec D. et al. A randomized controller study of propranolol for prevention of recurrent gastruintestinal bleeding in patients with cirrhosis: a final report. Hepatology, 1984, vol. 4, p. 355-358 *
Ohnishi A. et al. Kinetics and dynamics of enalapril in patients with liver cirrhosis. Clinical Pharmacology and Therapeutics, 1989, vol. 45, p. 657-665 *

Also Published As

Publication number Publication date
MD1780F1 (ro) 2001-11-30

Similar Documents

Publication Publication Date Title
IL135335A0 (en) Method for inhibiting or preventing hormone induced adverse effects and novel pharmaceutical compositions comprising carotenoids
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
ES2074698T3 (es) Composicion oral para el tratamiento de enfermedades intestinales inflamatorias.
IL175158A0 (en) Tocopherol-modified therapeutic drug compounds
HUP0102489A2 (hu) Biokémiai anyagok alkalmazása emberi test szerveiben található simaizomsejtek összehúzódása okozta egészségi állapotok megelőzésére és kezelésére alkalmas készítményekben
MXPA03006217A (es) Sistema de administracion espaciada de farmacos.
ATE298324T1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
MD2549F1 (ro) Metoda de tratament al hepatitei virale cronice C
HK1068606A1 (en) Novel aminobenzoephenones
MXPA01012936A (es) Composicion farmaceutica que contiene sibutramina y orlistat.
MD1780G2 (ro) Metodă de tratament al pacienţilor cu ciroze hepatice
ATE301452T1 (de) Verfahren zur herstellung einer flüssigen dosierungseinheit und kit
SE9800905D0 (sv) New therapy in glomerulonephritis
AR109456A2 (es) Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación
IL164763A0 (en) Byperforin derivatives, the use thereof and formulations containing them
MD1609F1 (ro) Metoda de tratament al stomatitei aftoase recidivante cronice
MD1610G2 (ro) Metodă de tratament al stomatitei aftoase recidivante cronice
MD1469G2 (ro) Metodă de tratament al şocului combustional
WO2003066806A3 (en) Therapeutic use of aziridino compounds
MD2068F1 (ro) Metoda de tratament al infectiei cu Herpes simplex
MD1783F1 (ro) Metoda de tratament al epilepsiei
RU2004107473A (ru) Способ терапии хронического перенапряжения организма спортсмена
WO2005011589A3 (en) Drug delivery methods and devices
MY128724A (en) Liver selective theraphy.